Navigation Links
'Microfluidic palette' may paint clearer picture of biological processes
Date:7/29/2009

The masterpieces that spring from the talents of Rembrandt, Van Gogh and other artists often begin with the creation of a gradient of colors on a palette. In a similar manner, researchers at the National Institute of Standards and Technology (NIST) have created an innovative device called the "microfluidic palette" to produce multiple, steady-state chemical gradientsgradual changes in concentration across an areain a miniature chamber about the diameter of a pinhead. The tool can be used to study the complex biological mechanisms in cells responsible for cancer metastasis, wound healing, biofilm formation and other fluid-related processes.

The advantage of the NIST system, as described in a new paper,* is that the gradients are generated by diffusionthe gentle movement of matter from one point to another by random molecular motion. Microfluidic systems usually mix fluids more actively, by pumps and the circulation of currents. Diffusion gradients allow cells being studied to remain in the microchamber without the chance of their being swept away. Diffusion also permits chemical molecules to move in and out of the cells naturally and eliminates the risk of shear stresses, commonly produced by currents, which could cause the cells to rupture or behave abnormally.

The NIST microfluidic palette manages this with a clever plumbing trick. The key element of the palette is the microchamber, a small disk-shaped area only 1.5 millimeters (0.06 inch) across etched into the center of a glass wafer. Tiny holes at its circumferencethree in the prototype, but it could be moreallow various mixtures to flow into the chamber. Beneath the chamber, each access port connects to the long tail of a Y-shaped channel etched into a second layer. These channels deliver test chemicals to the chamber. Fluid flow in and out of the short arms of each Y at constant pressure assures a constant stream of fresh chemicals. Because the pressure in the chamber is balanced by filling it previously with a buffer solution, the test chemicals that migrate from the channels into the chamber do so almost entirely by diffusion. Therefore, as long as a constant flow of fluid is maintained through the Y's, the gradients in the chamber can be maintained virtually indefinitely.

To demonstrate how the microfluidic palette works, the NIST researchers inject dyes of the three primary colorsred, yellow and blueseparately into the three inlets of the system. For each dye, an independent gradient forms that remains constant as long as flow rate into the system does not change. Overlapping the three gradients results in a blend of dye concentrations in which the combination of colors at one location is distinctly different from any other location.

Similarly, if three separate drugs were injected into the palette where the microchamber contained a culture of cells, individual cells at different locations in the chamber would be exposed to different combinations of the drugs. In a single experiment, one could easily study the effects of a wide range of mixed drug concentrations on the same cell type.

Another potential application of the microfluidic palette is the study of chemotaxis, the movement of cells along a chemical gradient, a biological phenomenon that plays a role in the spread of cancer (metastasis), wound healing, infection and carbon cycling in the ocean.


'/>"/>

Contact: Michael E. Newman
michael.newman@nist.gov
301-975-3025
National Institute of Standards and Technology (NIST)
Source:Eurekalert  

Related biology news :

1. Automated microfluidic device reduces time to screen small organisms for genetic studies
2. GEN reports on growing reliance on microfluidics technology
3. Nature leads the way for the next generation of paints, cosmetics and holograms
4. Worth a thousand words: Hopkins researchers paint picture of cancer-promoting culprit
5. Synchrotron light unveils oil in ancient Buddhist paintings from Bamiyan
6. Scientists paint viruses to track their fate in the body
7. Beaded viruses and geology-inspired paintings show the art in science
8. Antarctic fossils paint a picture of a much warmer continent
9. Neural mapping paints a haphazard picture of odor receptors
10. Complex carbon picture clearer
11. Chicks to give scientists clearer picture of fetal development
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
'Microfluidic palette' may paint clearer picture of biological processes
(Date:1/20/2016)... Jan. 20, 2016 A market that just ... benefit from the explosion in genomics knowledge. Learn all ... Research. A range of dynamic trends are pushing market ... personalized medicine - pharmacogenomics - pathogen evolution - next ... markets - greater understanding of the role of genetic ...
(Date:1/18/2016)... JOSE, Calif. , Jan. 18, 2016 /PRNewswire/ ... security software that simplifies the use and access ... technology and go-to-market partnership with American Cyber.  ... Cyber brings extensive experience leading transformational C4ISR and ... implementing and integrating the latest proven technology solutions," ...
(Date:1/13/2016)... , January 13, 2016 ... the addition of the  "India Biometrics ... & Forecast (2015-2020)"  report to ... ) has announced the addition of ... Market - Estimation & Forecast (2015-2020)" ...
Breaking Biology News(10 mins):
(Date:2/4/2016)... SHENZHEN, China , Feb. 4, 2016 ... government, and various medical institutions attended a ceremony in ... provide integrative, personalized cell therapy in 2016. ... the "Shenzhen Clinical Translation Platform for Personalized Cell Therapy" ... Shenzhen Regional Cell Production Center, both subsidiaries of Beike ...
(Date:2/4/2016)... BETHESDA, Md. , Feb. 4, 2016  Spherix ... committed to the fostering and monetization of intellectual property, ... VTech and Uniden in the Northern District of ... are moving forward.  Inter Partes ... the U.S. Patent Office.  The IPR was initiated on ...
(Date:2/3/2016)...   ViaCyte, Inc ., a leading, privately-held ... cell-derived islet replacement therapy for the treatment of ... that ViaCyte and Janssen Biotech, Inc., one of ... have agreed to consolidate the assets of the ... ViaCyte with an exclusive license to all BetaLogics ...
(Date:2/3/2016)... , Feb. 3, 2016 New ... more than $1 million for researchers in ... on health-related research that demonstrates exciting potential.   ... of funding for the New Jersey Health Foundation Research ... members at these educational institutions— Princeton University, Rutgers ...
Breaking Biology Technology: